blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3956291

EP3956291 - LOW TOXICITY ORGANIC TERTIARY AND QUATERNARY AMINES AND USES THEREOF [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  07.04.2023
Database last updated on 31.08.2024
FormerRequest for examination was made
Status updated on  21.01.2022
FormerThe international publication has been made
Status updated on  23.10.2020
Formerunknown
Status updated on  13.05.2020
Most recent event   Tooltip13.07.2024New entry: Reply to examination report 
Applicant(s)For all designated states
Advancion Corporation
1500 East Lake Cook Road
Buffalo Grove, IL 60089 / US
[2023/44]
Former [2022/08]For all designated states
ANGUS Chemical Company
1500 East Lake Cook Road
Buffalo Grove, IL 60089 / US
Inventor(s)01 / GREEN, G. David
2421 Grove Lane
Cary, Illinois 60013 / US
02 / QUINN, Jordan
514 Jennifer Circle
Mundelein, Illinois 60060 / US
 [2022/08]
Representative(s)Potter Clarkson
Chapel Quarter
Mount Street
Nottingham NG1 6HQ / GB
[N/P]
Former [2022/08]Potter Clarkson
The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
Application number, filing date20723748.815.04.2020
[2022/08]
WO2020US28299
Priority number, dateUS201962834928P16.04.2019         Original published format: US 201962834928 P
[2022/08]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020214692
Date:22.10.2020
Language:EN
[2020/43]
Type: A1 Application with search report 
No.:EP3956291
Date:23.02.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 22.10.2020 takes the place of the publication of the European patent application.
[2022/08]
Search report(s)International search report - published on:EP22.10.2020
ClassificationIPC:C07C211/09, C07C211/14, C07C215/08, C07C215/10, C07C217/08
[2022/08]
CPC:
C07C215/08 (EP,KR,US); C07C215/10 (EP,KR,US); C07C209/68 (KR,US);
C07C211/09 (EP,US); C07C211/14 (EP,KR,US); C07C211/63 (US);
C07C213/08 (US); C07C215/40 (US); C07C217/08 (EP,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/08]
TitleGerman:ORGANISCHE TERTIÄRE UND QUATERNÄRE AMINE MIT NIEDRIGER TOXIZITÄT UND IHRE VERWENDUNG[2022/08]
English:LOW TOXICITY ORGANIC TERTIARY AND QUATERNARY AMINES AND USES THEREOF[2022/08]
French:AMINES TERTIAIRES ET QUATERNAIRES ORGANIQUES À FAIBLE TOXICITÉ ET LEURS UTILISATIONS[2022/08]
Entry into regional phase09.11.2021National basic fee paid 
09.11.2021Designation fee(s) paid 
09.11.2021Examination fee paid 
Examination procedure09.11.2021Examination requested  [2022/08]
09.11.2021Date on which the examining division has become responsible
20.06.2022Amendment by applicant (claims and/or description)
11.04.2023Despatch of a communication from the examining division (Time limit: M04)
11.08.2023Reply to a communication from the examining division
12.03.2024Despatch of a communication from the examining division (Time limit: M04)
11.07.2024Reply to a communication from the examining division
Fees paidRenewal fee
20.03.2022Renewal fee patent year 03
14.03.2023Renewal fee patent year 04
13.03.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XA]WO2012050769  (DOW GLOBAL TECHNOLOGIES LLC [US], et al) [X] 1,2,4-8,11,13-15,20-22,27,29,30,35,36,39,41,43-49,51-54 * abstract * * bridging paragraph *; pages 4-5 * * examples 1-13 * * claims 1-14 * [A] 3,9,10,12,16-19,23-26,28,31-34,37,38,40,42,50,55;
 [XA]WO2013148613  (DOW GLOBAL TECHNOLOGIES LLC [US]) [X] 1-8,11,13,14,16,18,20-27,29,35,36,39,41,43-54 * abstract * * page 5 * * pages 1-3 * * claims 1-13 * [A] 9,10,12,15,17,19,28,30-34,37,38,40,42,55;
 [XA]US2013261039  (LITTLE CHARLES B [US]) [X] 1,2,4-12,16,17,27,28,35-54 * abstract * * paragraphs [0009] - [0032] * * paragraphs [0036] - [0043] * * paragraphs [0058] - [0105] * * examples 1-6 * * claims 1-16 * [A] 3,13-15,18-26,29-34,55;
 [XA]WO2015065842  (DOW GLOBAL TECHNOLOGIES LLC [US]) [X] 1,2,4-8,20-22,29,35-37,41,43,54 * abstract * * paragraphs [0005] , [0 21] - [0024] - [0 26] , [0 27] * * examples *; pages 15-21 * * claims 1-10 * [A] 3,9-19,23-28,30-34,38-40,42,55;
 [XA]US2016244606  (RAVICHANDRAN RAMANATHAN [US], et al) [X] 1,2,4-8,20-22,29,35-37,39,41,47,48,52-54 * abstract * * tables 8-10 * * claims 1-47 * [A] 3,9-19,23-28,30-34,38,40,42-46,49-51,55;
 [XA]WO2016186918  (DOW GLOBAL TECHNOLOGIES LLC [US]) [X] 1,2,4-8,20-22,29,35-37,39-41,43-54 * abstract * * pages 2, 6 * * examples *; pages 9-10 * * claims 1-12 * [A] 3,9-19,23-28,30-34,38,42,55;
 [XA]WO2017200211  (K C TECH CO LTD [KR]) [X] 1,2,4-8,20-22,29,35-39,41,43-50,52-54 * abstract * * paragraphs [0021] , [0 22] * * examples 1-11 * * claims 1-13 * [A] 3,9-19,23-28,30-34,40,42,51,55;
 [XA]US2018066011  (PARK HEE-SUNG [KR], et al) [X] 1,2,4-8,11,12,16,17,20,27,35,36,48,51-55 * paragraphs [0087] - [0088] * [A] 3,9,10,13-15,18,19,21-26,28-34,37-47,49,50;
 [XP]CN110669591  (SHANGHAI SINYANG SEMICONDUCTOR MAT CO LTD) [XP] 1,2,4-8,11,12,16,17,20-22,27,28,31,32,35-41,43-54 * abstract * * pages 6-7 * * pages 9-10; compounds A1-A29 ** claims 1-10 *;
 [XA]  - GUOBIN SUN ET AL, "Syntheses, Structures, and Enzymic Evaluations of Conformationally Constrained, Analog Inhibitors of Carnitine Acetyltransferase: (2R,6R)-, (2S,6S)-, (2R,6S)-, and (2S,6R)-6-(Carboxylatomethyl)-2-(hydroxymethyl)-2,4,4-trimethylmorpholinium", JOURNAL OF ORGANIC CHEMISTRY, US, (199510), vol. 60, no. 21, doi:10.1021/jo00126a018, ISSN 0022-3263, pages 6688 - 6695, XP055700577 [X] 1,2,4-8,20-22,29,30,35,36,41,44,47,51-54 * page 6689; compound 7 * * page 6695, column l, paragraph 2 * [A] 3,9-19,23-28,31-34,37-40,42,43,45,46,48-50,55

DOI:   http://dx.doi.org/10.1021/jo00126a018
 [XA]  - OHTSUKA YUHKI ET AL, "Cobalt/diamine-catalyzed 1,1-difluoroethylation and 2,2,2-trifluoroethylation of aryl Grignard reagents with corresponding fluoroalkyl halides", JOURNAL OF FLUORINE CHEMISTRY, ELSEVIER, NL, (20160317), vol. 185, doi:10.1016/J.JFLUCHEM.2016.03.007, ISSN 0022-1139, pages 96 - 102, XP029520083 [X] 1,3-5,20,22,24-26,33,35-37,48,51-54 * scheme 1 *; page 97 * * page 98; figure 1 * * page 98; tables 2, 3 * * pages 99-101; tables 4-7 * [A] 2,6-19,21,23,27-32,34,38-47,49,50,55

DOI:   http://dx.doi.org/10.1016/j.jfluchem.2016.03.007
 [XA]  - MICHAEL A. BECKETT ET AL, "Structural (XRD) and thermal (DSC, TGA) and BET analysis of materials derived from non-metal cation pentaborate salts", DALTON TRANSACTIONS, (201001), vol. 39, no. 16, doi:10.1039/b927072h, ISSN 1477-9226, page 3944, XP055700646 [X] 1,2,4-8,11,12,16,17,20,22,27,28,31,35,36,39,45,51-54 * bridging paragraph *; page 3944 - page 3945 * * page 3950, paragraph 3.3 * [A] 3,9,10,13-15,18,19,21,23-26,29,30,32-34,37,38,40-44,46-50,55

DOI:   http://dx.doi.org/10.1039/b927072h
 [XA]  - Ibert C Wells, "OXIDATION OF CHOLINE-LIKE SUBSTANCES BY RAT LIVER PREPARATIONS. INHIBITORS OF CHOLINE OXIDASE", Journal of Biological Chemistry, (19540101), pages 575 - 583, URL: https://www.jbc.org/content/207/2/575.full.pdf, (20200604), XP055700877 [X] 1,2,4-8,11,12,16,17,20,22,27,35,36,44,45,47,51-54 * pages 576-579 * * Table *; page 578 * * page 581; table II * [A] 3,9,10,13-15,18,19,21,23-26,28-34,37-43,46,48-50,55
 [XA]  - BECKETT M A ET AL, "A 11B NMR study of zwitterionic and cationic monoborate complexes with cationic 1,2-diol ligands", POLYHEDRON, PERGAMON PRESS, OXFORD, GB, vol. 27, no. 9-10, doi:10.1016/J.POLY.2008.04.007, ISSN 0277-5387, (20080626), pages 2226 - 2230, (20080605), XP022706154 [X] 1,2,4-8,11-14,27,28,35,36,41,44,45,47,48,51-54 * page 2226, paragraph 2.2. - page 2227 * * page 2227, paragraph 2.4. - page 228 * [A] 3,9,10,15-26,29-34,37-40,42,43,46,49,50,55

DOI:   http://dx.doi.org/10.1016/j.poly.2008.04.007
 [XA]  - LUKÁC MILOS ET AL, "Synthesis, self-aggregation and biological properties of alkylphosphocholine and alkylphosphohomocholine derivatives of cetyltrimethylammonium bromide, cetylpyridinium bromide, benzalkonium bromide (C16) and benzethonium chloride", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, ELSEVIER, AMSTERDAM, NL, (20130603), vol. 66, doi:10.1016/J.EJMECH.2013.05.033, ISSN 0223-5234, pages 46 - 55, XP028685927 [X] 1,2,4-8,11,12,16,17,20,27,35,36,48,51-55 * scheme 2 *; page 48 * * page 52, paragraph 4.1.3 * [A] 3,9,10,13-15,18,19,21-26,28-34,37-47,49,50

DOI:   http://dx.doi.org/10.1016/j.ejmech.2013.05.033
 [XA]  - CAROLIN EDINGER ET AL, "Electrochemical Deoxygenation of Aromatic Amides and Sulfoxides - Supporting information", EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, DE, (20140722), vol. 2014, no. 24, doi:10.1002/ejoc.201402714, ISSN 1434-193X, pages 1 - 33, XP055701013 [X] 1,3-5,7,11,12,16,17,20,24-27,35,36,48,51-55 * page 5 * [A] 2,6,8-10,13-15,18,19,21-23,28-34,37-47,49,50

DOI:   http://dx.doi.org/10.1002/ejoc.201402714
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.